MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Risk of Parkinson’s disease in zolpidem user: A systematic review and meta-analysis

    S. Hussain, A.K. Najmi, D. Anil (New Delhi, India)

    Objective: To explore the association between zolpidem use and risk of Parkinson's disorder. Background: Zolpidem is commonly prescribed for the treatment of sleep disorder. Epidemiological…
  • 2017 International Congress

    Impaired stress-induced mitophagy in parkinsonian LRRK2(R1441G) knockin mutant mice

    P.W.-l. Ho, C.S.-c. Lam, H.-f. Liu, G.C.-t. Leung, L. Li, M.H.-w. Kung, D. Ramsden, S.-l. Ho (Hong Kong, Hong Kong)

    Objective: 1. Morphological changes and accumulation of ubiquitinated mitochondria in the striatum of aged leucine-rich-repeat kinase 2 (LRRK2)R1441G knockin mutant mice (Liu et al., 2014,…
  • 2017 International Congress

    Prognostic relevance and predictive ability of data-driven PD subtypes in the Longitudinal and Biomarker Studies in Parkinson’s disease (LABS-PD)

    T. Mestre, S. Eberly, C. Tanner, D. Grimes, A. Lang, D. Oakes, C. Marras (Ottawa, ON, Canada)

    Objective: To assess the prognostic relevance and predictive ability of a PD subtype classification system generated in LABS-PD cohort. Background: PD subtype classification systems have…
  • 2017 International Congress

    Plasma Biomarkers in Idiopathic Normal Pressure Hydrocephalus

    P.-W. Ko, K. Kang, S.Y. Kim, H.-W. Lee (Daegu, Republic of Korea)

    Objective: (1) To investigate the role of plasma biomarkers that is known to related to Alzheimer’s disease in INPH(2) To assess the diagnostic and prognostic…
  • 2017 International Congress

    Does Parkinsons KinetiGraph (PKG) recording help in clinical decision making? A local experience

    N. Wilson, R. Mappilakkandy, M. Smith, K. Nithi (Northampton, United Kingdom)

    Objective: To evaluate the use of the PKG to aid clinical management decisions in a district general hospital. Background:  Clinicians treating Parkinson's disease (PD) must…
  • 2017 International Congress

    More effective rTMS site for the freezing of gait in Parkinson’s disease

    S.Y. Kang, S.J. Kim (Hwaseong, Republic of Korea)

    Objective: The aim of study is to find brain stimulation areas showing more effective response. Background: Freezing of gait (FOG) is frustrating problem in Parkinson’s…
  • 2017 International Congress

    RBD predicts the cognitive impairment in Parkinson’s disease

    E. Stefanova, T. Stojkovic, I. Stankovic, V. Kostic (Belgrade, Serbia)

    Objective: To assess the relationship between the presence of Rapid eye movement  sleep and behavior disorders RBD and the cognitive decline of non-demented patients with PD in…
  • 2017 International Congress

    Validation of a performance-based assessment of functional ability related to cognition in Parkinson’s disease

    S. Holden, L. Medina, B. Hoyt, S. Sillau, J. Goldman, D. Weintraub, B. Kluger (Aurora, CO, USA)

    Objective: Validate the University of California San Diego Performance-Based Skills Assessment (UPSA) in Parkinson's disease (PD) Background: Diagnostic criteria for PD dementia (PDD) require significant…
  • 2017 International Congress

    Apolipoprotein E ε4 allele frequency in Korean Patients with Parkinson’s disease Dementia

    M. Park (Daegu, Republic of Korea)

    Objective: The Apo E allele frequencies were evaluated in Korean patients with probable PDD diagnosed by the MDS task force criteria for the diagnosis of…
  • 2017 International Congress

    A neuronal model of PARK20 (SYNJ1 mutation) using patient derived iPSCs

    R. Masius, M. Minneboo, M. Grochowska, M. Quadri, M. Picillo, P. Barone, V. Bonifati, W. Mandemakers (Rotterdam, Netherlands)

    Objective: The SYNJ1 homozygous mutation (p.Arg258Gln) leads to juvenile Parkinsonism (PARK20). SYNJ1 plays an important role in synaptic vesicle cycling, and regulating autophagic flux. We…
  • « Previous Page
  • 1
  • …
  • 284
  • 285
  • 286
  • 287
  • 288
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley